Ashokarishta in classical Ayurveda

What it is

Ashokarishta is an arishta: ashoka bark (Saraca asoca) decoction fermented with jaggery and prakshepa herbs, yielding a self-generated-alcohol liquid medicine. The trial protocol notes that Ashokarishta is indicated in Ayurvedic classics and the Ayurvedic Formulary of India, and explicitly states that "no clinical trial has been carried out on these formulations" (Rajput et al., JMIR Research Protocols, 2025; PubMed).

Classical properties

• Taste (rasa): astringent (Kashaya), bitter (Tikta)
• Qualities (guna): light (Laghu)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Pitta and Kapha; may increase Vata

Traditional use

Classical texts and long-standing practice use Ashokarishta for raktapradara (menorrhagia), irregular menstruation, dysmenorrhea-type complaints, and leucorrhoea. It is among the most prescribed Ayurvedic medicines for women's health. These are traditional claims, not clinical proof.

What research has looked at

Randomized trial underway (protocol; results not yet published)

CCRAS researchers published a protocol for an open-label randomized controlled trial in menorrhagia: 140 women planned (79 enrolled as of December 2024), with the treatment arm receiving Ashokarishta plus Trinakantamani pishti plus iron/folic acid for 3 months, versus tranexamic acid plus iron/folic acid in the control arm. Primary outcomes are menstrual blood loss (Pictorial Blood Loss Assessment Chart) and bleeding duration. Data analysis was expected by February 2026. As of September 2026, no results had been published. A protocol is a plan, not evidence (same protocol). Never use it in place of, or alongside, prescribed medicine without your doctor.

Weak case reports only

The only published clinical material located is a weak single-case report, which cannot support efficacy claims. Case reports sit at the bottom of the evidence hierarchy.

What the evidence does not support (yet)

No completed study supports Ashokarishta for menorrhagia, menstrual regulation, or any gynecological condition. Its reputation rests entirely on classical authority and practice. The CCRAS trial is the first real test; until its results publish, efficacy is unproven.

Safety notes

Ashokarishta contains self-generated alcohol: avoid in pregnancy, lactation, and alcohol dependence. Heavy menstrual bleeding can signal fibroids, endometriosis, bleeding disorders, or malignancy, and severe anemia is dangerous; do not self-treat heavy bleeding with Ashokarishta instead of gynecological evaluation. Iron deficiency from chronic blood loss needs proper assessment. In the trial protocol, Ashokarishta was combined with iron/folic acid, not used as a stand-alone anemia treatment.

FAQs

Does Ashokarishta work for heavy periods?

Unknown. No completed trial exists. A randomized trial is underway, but its results, expected in early 2026, had not been published as of September 2026.

Can it be taken for irregular periods?

Traditional practice does, but without trial evidence. New menstrual irregularity, especially with heavy bleeding, deserves medical evaluation first.

Is it safe in pregnancy?

No. Avoid alcohol-containing ferments in pregnancy, and never self-treat bleeding in pregnancy with herbal medicines.

What is Trinakantamani pishti?

A classical mineral preparation combined with Ashokarishta in the ongoing trial. It is not separately evidence-backed for menorrhagia.

Sources

Protocol for an ongoing CCRAS open-label randomized trial of Ashokarishta plus Trinakantamani pishti and iron/folic acid versus tranexamic acid in menorrhagia (140 planned; results pending): Rajput et al., JMIR Res Protoc 2025 (PubMed 40163851).

Disclaimer

Ashokarishta has no proven efficacy for menstrual disorders. Heavy menstrual bleeding requires gynecological evaluation to exclude serious causes; do not self-treat it with herbal ferments. This article is educational, not medical advice.